Literature DB >> 11357803

A case of effusive-constrictive pericarditis after cardiac surgery.

M Ito1, Y Tanabe, K Suzuki, M Kumakura, K Nakayama, H Kanazawa, Y Yamazaki, Y Aizawa.   

Abstract

A 60-year-old woman who had undergone repair of an atrial septal defect was readmitted to the hospital with dyspnea, abdominal distention, and leg edema 31 months after surgery. An echocardiogram demonstrated massive pericardial effusion. Cardiac catheterization revealed elevation and equilibrium of the 4-chamber diastolic pressure and a dip-and-plateau pattern in the right and the left ventricular pressures. Despite removal of pericardial fluid by pericardiocentesis, the findings and symptoms did not improve. The patient underwent both parietal and visceral pericardiectomy after which striking hemodynamic and symptomatic improvement occurred. Effusive-constrictive pericarditis is uncommon but should be considered in patients with refractory heart failure and massive pericardial effusion showing no improvement after removal of pericardial fluid.

Entities:  

Mesh:

Year:  2001        PMID: 11357803     DOI: 10.4065/76.5.555

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

1.  Effusive--constrictive epicarditis that developed more than 5 years after ventricular septal defect closure: two cases relieved by epicardiectomy.

Authors:  N Okamoto; H Shiraishi; H Konishi; M Y Momoi
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

Review 2.  Effusive-constrictive pericarditis.

Authors:  Faisal F Syed; Mpiko Ntsekhe; Bongani M Mayosi; Jae K Oh
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

3.  Severe heart failure due to subacute effusive-constrictive pericarditis in a child.

Authors:  C Suita; I Shiraishi; T Tanaka; K Shuntoh; M Yamagishi; K Hamaoka
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

4.  Surgical management of effusive constrictive pericarditis.

Authors:  Fuat Buyukbayrak; Eray Aksoy; Serpil Tas; Kaan Kirali
Journal:  Cardiovasc J Afr       Date:  2013-09-16       Impact factor: 1.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.